Home/Filings/4/0001415889-21-001827
4//SEC Filing

Peacock Jonathan M 4

Accession 0001415889-21-001827

CIK 0001600132other

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 4:10 PM ET

Size

4.6 KB

Accession

0001415889-21-001827

Insider Transaction Report

Form 4
Period: 2021-03-31
Peacock Jonathan M
DirectorPresident and CEO
Transactions
  • Award

    Common Stock

    2021-03-31+15,308157,033 total
Footnotes (1)
  • [F1]RSAs fully vested on grant date.

Issuer

Bellerophon Therapeutics, Inc.

CIK 0001600132

Entity typeother

Related Parties

1
  • filerCIK 0001500241

Filing Metadata

Form type
4
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 4:10 PM ET
Size
4.6 KB